Short answer
Elevance Health (ELV) filed an 8-K current report with the SEC on July 15, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 financial results for quarter ended June 30, 2026.
Elevance Health 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 financial results for quarter ended June 30, 2026
- Press release issued July 15, 2026, with detailed results in Exhibit 99.1
Item EX-99.1 · Exhibit EX-99.1
- 2Q revenue $49.8B, up 0.8%, but operating gain fell 27.3% to $1.8B as margin compressed to 3.5% from 4.9%
- Adjusted EPS $7.45, supported by favorable benefit performance and an approximately $0.80 per-share below-the-line benefit
- FY 2026 adjusted EPS guidance raised to at least $27.00, while operating cash flow guidance increased to at least $6.0B
- Health Benefits weakened materially: operating gain down 42.6% to $896M, margin 2.1%, with membership down 1.5% year over year
- Medical cost pressure remains key risk: benefit expense ratio rose 80 basis points to 89.7%, while operating expenses increased 11.0%
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Elevance Health 8-K filings
Get the next ELV 8-K as it lands
Follow ELV for push alerts, or ask the research agent what this filing means.